Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Another option would be if the person responds to risperidone and it's a beautiful response and they have no side effects and they really don't want to change and you don't want to change because they've had a great antipsychotic response to the drug or great behavioral response (for example, in autism), you can give them a dopamine agonist to compete with the drug in the pituitary and see if you can bring down their prolactin
Tirzepatide Description: Tirzepatide, marketed as Mounjaro, is a dual GIP and GLP-1 receptor agonist used for managing type 2 diabetes and obesity
References Zoe Diana Draelos, DeliencourtGodefroy, G., & Lopes, L
GLP-1 receptor agonists are not recommended during pregnancy or breastfeeding
